104 related articles for article (PubMed ID: 9933797)
1. Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma.
Lahn M; Fisch P; Köhler G; Kunzmann R; Hentrich I; Jesuiter H; Behringer D; Muschal B; Veelken H; Kulmburg P; Iklé DN; Lindemann A
Eur Urol; 1999 Jan; 35(1):70-80. PubMed ID: 9933797
[TBL] [Abstract][Full Text] [Related]
2. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
3. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.
Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT
Cancer Immunol Immunother; 1995 Aug; 41(2):111-21. PubMed ID: 7656270
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
[TBL] [Abstract][Full Text] [Related]
6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
7. Characterization of primary renal carcinoma cultures.
Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-beta 1 in primary cultures and modulate T lymphocyte blast transformation.
Knoefel B; Nuske K; Steiner T; Junker K; Kosmehl H; Rebstock K; Reinhold D; Junker U
J Interferon Cytokine Res; 1997 Feb; 17(2):95-102. PubMed ID: 9058315
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
11. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
12. Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Figel AM; Brech D; Prinz PU; Lettenmeyer UK; Eckl J; Turqueti-Neves A; Mysliwietz J; Anz D; Rieth N; Muenchmeier N; Buchner A; Porubsky S; Siegert SI; Segerer S; Nelson PJ; Noessner E
Am J Pathol; 2011 Jul; 179(1):436-51. PubMed ID: 21703422
[TBL] [Abstract][Full Text] [Related]
13. Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cells.
Klaver Y; van Steenbergen SCL; Sleijfer S; Debets R; Lamers CHJ
Clin Immunol; 2016 Aug; 169():107-113. PubMed ID: 27377533
[TBL] [Abstract][Full Text] [Related]
14. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
[TBL] [Abstract][Full Text] [Related]
15. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
[TBL] [Abstract][Full Text] [Related]
16. Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart.
D' Hooghe E; Buttiglieri S; Bisignano G; Brusa D; Camussi G; Matera L
Int J Immunopathol Pharmacol; 2007; 20(4):707-17. PubMed ID: 18179743
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.
Chuang MJ; Sun KH; Tang SJ; Deng MW; Wu YH; Sung JS; Cha TL; Sun GH
Cancer Sci; 2008 May; 99(5):905-13. PubMed ID: 18294286
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.
Kudo D; Rayman P; Horton C; Cathcart MK; Bukowski RM; Thornton M; Tannenbaum C; Finke JH
Cancer Res; 2003 Apr; 63(7):1676-83. PubMed ID: 12670922
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
[TBL] [Abstract][Full Text] [Related]
20. IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.
Falkensammer C; Jöhrer K; Gander H; Ramoner R; Putz T; Rahm A; Greil R; Bartsch G; Thurnher M
Cancer Immunol Immunother; 2006 Oct; 55(10):1228-37. PubMed ID: 16810557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
